The Lancet Gastroenterology & Hepatology in conversation with

A new drug for short bowel syndrome

April 05, 2019 The Lancet
The Lancet Gastroenterology & Hepatology in conversation with
A new drug for short bowel syndrome
Show Notes

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv